are illnesses caused by infectious agents such as bacteria, viruses, fungi and parasites. The infectious diseases are mostly communicable and are also transmitted by bites from insects or animals, or by exposure to organisms in the environment. Other infectious diseases can affect organisms that ingest contaminated food or water. The impacts of these diseases are immense and can be felt across the world. Among the almost infinite varieties of microorganisms, relatively few are responsible for causing disease in otherwise healthy individuals. These disease causing microorganisms are known as pathogens.
Infectious disease results from the interaction between those few pathogens and the defenses of the hosts they infect. The form and severity of the diseases resulting from any pathogen depends upon the ability of that pathogen to damage the host as well as the immunity of the host to resist the pathogen.
The development of diagnostics of infectious diseases has resulted from advances in the field of chemistry, immunology, molecular biology, engineering, automation, and nucleic acid amplification. It is now possible to determine the specific etiology of a patient’s infectious disease in the hospital, clinic, office, or even a patient’s home.
The global market for infectious disease testing
was estimated to be $XX billion in 2015 and is estimated to grow at a CAGR of XX% to reach $XX billion by 2021. The factors effecting the growth of infectious diseases is contaminated ground water, faulty water purification, changing in rendering process etc., the infectious diseases forecast to have the highest growth of X% during the forecast period 2016-2021. Oil & gas, Hospitals and Laboratories are the major end-users for infectious disease testing.
On the basis of region, the Infectious disease testing market is segmented into North America, Europe, Asia-Pacific, and the Rest of World (RoW). In 2015, North America accounted for the largest share of the Infectious disease testing market, followed by Europe. Both markets are estimated to register single-digit growth rates over the next five years. However, Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the high prevalence of infectious diseases, and huge investment opportunities due to increase in healthcare expenditure.